Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06225154
Other study ID # SAG-C-DRP-100216-0041
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2015
Est. completion date November 2016

Study information

Verified date January 2024
Source Marmara University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present study aimed to determine the effect of non-surgical periodontal treatment (NSPT) on serum and salivary adipokine and interleukin-1β levels in periodontitis patients with or without type 2 Diabetes Mellitus (T2DM).


Description:

The present study aimed to determine the effect of non-surgical periodontal treatment (NSPT) on serum and salivary adipokine and interleukin (IL)-1β levels in periodontitis patients with or without type 2 Diabetes Mellitus (T2DM). A total of 80 patients; 20 healthy, 20 T2DM with periodontitis (P), 20 T2DM periodontally healthy, 20 systemically healthy with P were included in this study. At baseline, serum and saliva samples were collected and the whole mouth clinical periodontal parameters were recorded. Periodontitis patients received NSPT in 4 sessions. Clinical parameters were re-measured and samples were re-collected at 1 and 3 months after treatment. Serum and salivary levels of adipokines and IL-1β were analyzed using a flow cytometry-based technique of Lumina® map™. Data were analyzed using appropriate statistical tests.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date November 2016
Est. primary completion date May 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria: - Diabetes mellitus should be diagnosed for =1 year and HbA1c level should be at least %6,5 - Periodontitis should be diagnosed for at least 4 teeth with probing depth =5 mm with bleeding on probing (BOP) and also radiographic alveolar bone loss should be presence - Presence of at least 15 teeth Exclusion Criteria: - Received antibiotic treatment in the previous 3 months - Smokers - Pregnancy and lactation - Received periodontal treatment in the previous 6 months - Presence of less than 15 teeth - Having major diabetic complications

Study Design


Intervention

Procedure:
Non-surgical periodontal treatment
Non-surgical periodontal treatment was performed in a quadrant-wise manner at 1-week intervals.

Locations

Country Name City State
Finland Department of Periodontology, Institute of Dentistry, Turku University Turku Lemminkäisenkatu 2
Turkey Marmara University, Faculty of Dentistry, Department of Periodontology Istanbul Maltepe

Sponsors (2)

Lead Sponsor Collaborator
Marmara University University of Turku

Countries where clinical trial is conducted

Finland,  Turkey, 

References & Publications (3)

Furugen R, Hayashida H, Yamaguchi N, Yoshihara A, Ogawa H, Miyazaki H, Saito T. The relationship between periodontal condition and serum levels of resistin and adiponectin in elderly Japanese. J Periodontal Res. 2008 Oct;43(5):556-62. doi: 10.1111/j.1600-0765.2008.01085.x. Epub 2008 Jun 28. — View Citation

Gokhale NH, Acharya AB, Patil VS, Trivedi DJ, Setty S, Thakur SL. Resistin levels in gingival crevicular fluid of patients with chronic periodontitis and type 2 diabetes mellitus. J Periodontol. 2014 Apr;85(4):610-7. doi: 10.1902/jop.2013.130092. Epub 2013 Jun 27. — View Citation

Goncalves TE, Zimmermann GS, Figueiredo LC, Souza Mde C, da Cruz DF, Bastos MF, da Silva HD, Duarte PM. Local and serum levels of adipokines in patients with obesity after periodontal therapy: one-year follow-up. J Clin Periodontol. 2015 May;42(5):431-9. doi: 10.1111/jcpe.12396. Epub 2015 Apr 30. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Probing Depth (mm) probing depth measured from the gingival margin seldom corresponds to sulcus or pocket depth in mm. Change baseline, 1 and 3 months after non-surgical periodontal treatment
Other Plaque Index The measurement of the state of oral hygiene by Silness-Löe plaque index is based on recording both soft debris and mineralized deposits on the following teeth. Values 0,1,2 and 3 can be taken. While 0 indicates the least value, 3 indicates the maximum value. Change baseline, 1 and 3 months after non-surgical periodontal treatment
Other Gingival Index A measure of periodontal disease based on the severity and location of the lesion. Values 0,1,2 and 3 can be taken. While 0 indicates the least value, 3 indicates the maximum value. Change baseline, 1 and 3 months after non-surgical periodontal treatment
Other Bleeding on Probing (%) Percentage of bleeding sites. Bleeding on probing, often abbreviated BOP, is a sign of inflammation and indicates some sort of destruction and erosion to the lining of the sulcus or the ulceration of sulcular epithelium. The blood comes from lamina propria after the ulceration of the lining. Change baseline, 1 and 3 months after non-surgical periodontal treatment
Other Clinical Attachment Level (mm) The estimated position of structures that support the tooth as measured with a periodontal probe in mm; provides an estimate of a tooth's stability and of loss of bone support. Change baseline, 1 and 3 months after non-surgical periodontal treatment
Primary Serum and Salivary Resistin Levels (pg/ml) Serum and salivary resistin levels Change between baseline, 1 and 3 months after non-surgical periodontal treatment
Primary Serum and Salivary Leptin Levels (pg/ml) Serum and salivary leptin levels Change baseline, 1 and 3 months after non-surgical periodontal treatment
Primary Serum and Salivary Visfatin Levels (pg/ml) Serum and salivary visfatin levels Change baseline, 1 and 3 months after non-surgical periodontal treatment
Primary Serum and saliva IL-1ß levels (pg/ml) Serum and salivary IL-1ß levels Change baseline, 1 and 3 months after non-surgical periodontal treatment
Secondary HbA1c ( %) Glycated Hemoglobin Level % Change baseline, 1 and 3 months after non-surgical periodontal treatment
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2